Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05910775 · ClinicalTrials.gov registry record · NA
Role Of Non-Specific Effects in The Treatment of Depression With Esketamine
A NA study, sponsored by Yale University.
- Terminated
- Registry status
- NA
- Development phase
- 1
- Enrollment target
NCT05910775: Clinical Trial NA study, sponsored by Yale University.
NCT05910775 is a NA study that was terminated before completion, run by Yale University. The registered enrollment target is 1 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT05910775, a NA study, was terminated before completion, sponsored by Yale University.
- TERMINATED
- Registry status
- NA
- Development phase
- 1 participants
- Enrollment target
Study Summary
The investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific effects can be used effectively to improve the effectiveness of treatment with esketamine.
Primary Outcome
Participants' expectations will be assessed by the change in the group score of item 6 of the CEQ-6 at baseline and after the presentation (before treatment 1). Item 6 is scored from 0% (not at all) to 100% (very much). Higher scores indicates expectations have been met.
Interventions
- BEHAVIORAL Pre and Post Treatment Presentations
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1 participants |
| Start Date | 2024-07-13 |
| Est. Completion | 2024-12-31 |
| Phase | NA |
Why NCT05910775 stopped before completion
NCT05910775 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 1 participants, a relatively small participant target, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (100% lower).
The record links to 0 conditions, and to 1 intervention - of which Pre and Post Treatment Presentations is the first listed.
NCT05910775 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT05910775 about?
NCT05910775 is a clinical study titled "Role Of Non-Specific Effects in The Treatment of Depression With Esketamine". The investigators aim to examine the magnitude of non-specific effects in the treatment of depressive episodes with esketamine, by providing patients in the intervention group with a pretreatment presentation and post-treatment follow up session, to assess whether nonspecific effects can be used eff...
What is the current status of trial NCT05910775?
This trial is currently terminated. It is a NA study. The enrollment target is 1 participants. The study started on 2024-07-13. Estimated completion is 2024-12-31.
What interventions are being tested in trial NCT05910775?
The interventions under investigation include: Pre and Post Treatment Presentations (BEHAVIORAL).
Who is sponsoring clinical trial NCT05910775?
This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT05910775's enrollment target sits among peer trials
1 2001st of 2000 the lowest of 2,000 other NA trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI